Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ONTX - Onconova Therapeutics Inc. (ONTX) CEO Steve Fruchtman on Q1 2022 Results - Earnings Call Transcript

ONTX - Onconova Therapeutics Inc. (ONTX) CEO Steve Fruchtman on Q1 2022 Results - Earnings Call Transcript

Onconova Therapeutics Inc.
Onconova Therapeutics, Inc. (ONTX) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Avi Oler - Senior Vice President-Corporate Development and General Counsel Steve Fruchtman - President and Chief Executive Officer Mark Gelder - Chief Medical Officer Mark Guerin - Chief Financial Officer Conference Call Participants Charles Zhu - Guggenheim Ahu Demir - Ladenburg Joe Pantginis - H.C. Wainright Robert LeBoyer - Noble Capital Markets Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics' First Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared [Technical Difficulty] [Operator Instructions] As a reminder, this call is being recorded today, May 11,022. At this time, I'd like to turn the call over to Avi Oler, Senior Vice President of Corporate Development and General Counsel. Avi Oler Thank you operator, and

For further details see:

Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Onconova Therapeutics Inc.
Stock Symbol: ONTX
Market: NASDAQ
Website: onconova.com
Menu
ONTX ONTX Quote ONTX Short ONTX News ONTX Articles ONTX Message Board
Get ONTX Alerts

News, Short Squeeze, Breakout and More Instantly...